CAPTRUST FINANCIAL ADVISORS - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 154 filers reported holding REATA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 3.61 and the average weighting 0.2%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$1,279,088
+127808.8%
12,545
+46363.0%
0.01%
Q2 2022$1,000
-87.5%
27
-88.4%
0.00%
Q1 2022$8,000
+700.0%
233
+796.2%
0.00%
Q4 2021$1,000
-92.3%
26
-80.0%
0.00%
Q3 2021$13,000
-43.5%
130
-18.8%
0.00%
Q2 2021$23,000
+666.7%
160
+384.8%
0.00%
Q1 2021$3,000330.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
CPMG Inc 2,896,901$288,821,00055.24%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 100,000$9,970,00015.20%
Tolleson Wealth Management, Inc. 108,000$10,768,0003.25%
MADDEN SECURITIES Corp 34,787$3,468,0002.03%
Biondo Investment Advisors, LLC 101,204$10,090,0002.01%
LBJ Family Wealth Advisors, Ltd. 30,368$3,027,0001.91%
Duquesne Family Office 749,897$74,765,0001.65%
Sofinnova Investments, Inc. 238,520$23,780,0001.43%
Camber Capital Management LP 400,000$39,880,0001.37%
Integral Health Asset Management, LLC 44,000$4,387,0001.25%
View complete list of REATA PHARMACEUTICALS INC shareholders